Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
Nearly one in five women worldwide are now living with obesity
Paves way for CNS cancer test rollout
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
Subscribe To Our Newsletter & Stay Updated
